Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype

Nature Communications

Volumn 6, Issue , 2015, Pages

  Connor, Yamicia ^a,b,c,d   Tekleab, Sarah ^c   Nandakumar, Shyama ^c   Walls, Cherelle ^c   Tekleab, Yonatan ^b   Husain, Amjad ^d,e   Gadish, Or ^a,b   Sabbisetti, Venkata ^c,d   Kaushik, Shelly ^f   Sehrawat, Seema ^c   Kulkarni, Ashish ^a,c,d   Dvorak, Harold ^d,e   Zetter, Bruce ^d,g,h   R Edelman, Elazer ^a,b,c,d   Sengupta, Shiladitya ^a,c,d,h  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f India Innovation Research Center   (India)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; NANOMATERIAL;

CANCER; CELLS AND CELL COMPONENTS; GENETIC MARKER; INHIBITION; PATHOLOGY; PHENOTYPE; RNA; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST METASTASIS; CELL COMMUNICATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; IN VIVO STUDY; METASTATIC MELANOMA; MOUSE; NONHUMAN; PHENOTYPE; REGULATORY MECHANISM; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL; VASCULAR SMOOTH MUSCLE CELL; CELL ADHESION; CYTOLOGY; HUMAN; METASTASIS; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

CELL ADHESION; CELL COMMUNICATION; CELL LINE, TUMOR; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84951842560     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9671     Document Type: Article

References (60)

1. Zetter, B. R. Angiogenesis and tumour metastasis. Annu. Rev. Med. 49, 407-424 (1998).
2. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
3. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996).
4. Sethi, N. & Kang, Y. Unravelling the complexity of metastasis- molecular understanding and targeted therapeutics. Nat. Rev. Cancer 11, 735-748 (2011).
5. Eckhardt, B., Francis, P. A., Parker, B. S. & Anderson, R. L. Strategies for the discovery and development of therapies for metastatic breast cancer. Nat. Rev. Drug Discov. 11, 479-497 (2012).
6. Folkman, J. & DAmore, P. A. Blood vessel formation: what is its molecular basis? Cell 87, 1153-1155 (1996).
7. Frances, J. W., Baker, A. B., Chitalia, V. C. & Edelman, E. R. Stromal endothelial cells directly influence cancer progression. Sci. Transl. Med. 3, 66ra5 (2011).
8. Welti, J., Loges, S., Dimmeler, S. & Carmeliet, P. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J. Clin. Invest. 123, 3190-3200 (2013).
9. Sengupta, S., et al. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 23, 69-75 (2003).
10. Cao, Y., et al. Forty-year journey of angiogenesis translational research. Sci. Transl. Med. 3, 114rv3 (2011).
11. Zhuang, G., et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J. 31, 3513-3523 (2012).
12. Steeg, P. S. & Theodorescu, D. Metastasis: a therapeutic target for cancer. Nat. Clin. Pract. Oncol. 5, 206-219 (2008).
13. Peinado, H., et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891 (2012).
14. Mierke, C. T. Role of the endothelium during tumour cell metastasis: is the endothelium a barrier of a promoterfor cell invasion and metastasis. J. Biophys. 183516 (2008).
15. Mierke, C. T., et al. Breakdown of the endothelial barrier function in tumour cell transmigration. Biophys. J. 94, 2832-2846 (2008).
16. Png, K. J., Halberg, N., Yoshida, M. & Tavazoie, S. F. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481, 190-194 (2011).
17. Zhou, W., et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 25, 501-515 (2014).
18. Mina, L. A. & Sledge, Jr G. W. Rethinking the metastatic cascade as a therapeutic target. Nat. Rev. Clin. Oncol. 8, 325-332 (2011).
19. Sherer, N. M. & Mothes, W. Cytonemes and tunneling nanotubules in cells. Trends Cell Biol. 18, 414-420 (2008).
20. Roy, S., Huang, H., Liu, S. & Kornberg, T. B. Cytoneme-mediated contactdependent transport of the Drosophila decapentaplegic signaling protein. Science 343, 1244624 (2014).
21. Gurke, S., Barroso, J. F. & Gerdes, H. H. The art of cellular communication: tunneling nanotubes bridge the divide. Histochem. Cell Biol. 129, 539-550 (2008).
22. Sowinski, S., et al. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat. Cell Biol. 10, 211-219 (2008).
23. Onfelt, B., et al. Structurally distinct membrane nanotubes between human macrophages support long-distance vesicular traffic or surfing of bacteria. J. Immunol. 177, 8476-8483 (2006).
24. Gerdes, H. H. & Carvalho, R. N. Intercellular transfer mediated by tunneling nanotubes. Curr. Opin. Cell Biol. 20, 470-475 (2008).
25. Watkins, S. C. & Salter, R. D. Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity 23, 309-318 (2005).
26. Pasquier, J., et al. Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. J. Transl. Med. 11, 94 (2013).
27. Thayanithy, V., Dickson, E. L., Steer, C., Subramanian, S. & Lou, E. Tumour-stromal cross talk: direct cell-to-cell transfer of oncogenic microRNAs via tunneling nanotubes. Transl. Res. 164, 359-365 (2014).
28. Climent, M., et al. TGFb triggers miR143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization. Circ. Res. 116, 1753-1764 (2015).
29. Debnath, J. & Brugge, J. S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 5, 675-688 (2005).
30. Montesano, R., Orci, L. & Vassali, P. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J. Cell Biol. 97, 1648-1652 (1983).
31. Rustom, A., Saffrich, R., Markovic, I., Walther, P. & Gerdes, H. H. Nanotubular highways for intercellular organelle transport. Science 303, 1007-1010 (2004).
32. Vale, R. D. Myosin V motor proteins marching stepwise towards a mechanism. J. Cell Biol. 163, 445-450 (2003).
33. Ito, A., et al. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J. Clin. Invest. 105, 1189-1197 (2000).
34. Bukoreshtliev, N. V., et al. Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells. FEBS Lett. 583, 1481-1488 (2009).
35. Haglund, K., Nezis, I. P. & Stenmark, H. Structure and functions of stable intercellular bridges formed by incomplete cytokinesis during development. Commun. Integr. Biol. 4, 1-9 (2011).
36. Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688 (2007).
37. Anand, S., et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med. 16, 909-914 (2010).
38. Mouw, J. K., et al. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nat. Med. 20, 360-367 (2014).
39. Suárez, Y., et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Natl Acad. Sci. USA 105, 14082-14087 (2008).
40. Heusschen, R., van Gink, M., Griffioen, A. W. & Thijssen, V. L. MicroRNAs in the tumour endothelium: novel controls on the angioregulatory switchboard. Biochim. Biophys. Acta 1805, 87-96 (2010).
41. Zhang, Y., Yang, P. & Wang, X. F. Microenvironmental regulation of cancer metastasis by miRNAs. Trends Cell Biol. 24, 153-160 (2014).
42. Luo, D., et al. A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells. J. Transl. Med. 11, 57 (2013).
43. Chen, Z. L., et al. MicroRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J. Biol. Chem. 286, 10725-10734 (2011).
44. Chiang, C. H., Hou, M. F. & Hung, W. C. Up-regulation of miR-182 by b-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. Biochim. Biophys. Acta 1830, 3067-3076 (2013).
45. Yan, L., Huang, X. & Shao, Q. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14, 2348-2360 (2008).
46. Yu, Z. Y., Bai, Y. N., Luo, L. X., Wu, H. & Zeng, Y. Expression of microRNA-150 targeting vascular endothelial growth factor-A is downregulated under hypoxia during liver regeneration. Mol. Med. Rep. 8, 287-293 (2013).
47. Xiao, F., et al. MicroRNA-885-3p inhibits the growth of HT-29 colon cancer cell xenografts by disrupting angiogenesis via targeting BMPR1A and blocking BMP/Smad/Id1 signaling. Oncogene 34, 1968-1978 (2015).
48. Steeg, P. S. Tumour metastasis: mechanistic insights and clinical challenges. Nat. Med. 12, 895-904 (2006).
49. Rashid, O. M., et al. Is tail vein injection a relevant breast cancer lung metastasis model? J. Thorac. Dis. 5, 385-392 (2013).
50. Franses, J. W., Drosu, N. C., Gibson, W. J., Chitalia, V. C. & Edelman, E. R. Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis. Int. J. Cancer 133, 1334-1344 (2013).
51. Valadi, H., et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007).
52. Nygren, M. K., et al. Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c. Br. J. Cancer 110, 2072-2080 (2014).
53. Seaman, S., et al. Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 11, 539-554 (2007).
54. Mesri, M., et al. Identification and characterization of angiogenesis targets through proteomic profiling of endothelial cells in human cancer tissues. PLoS ONE 8, e78885 (2013).
55. Broll, K., Richter, G., Pauly, S., Hofstaedter, F. & Schwarz, H. CD137 expression in tumour vessel walls. High correlation with malignant tumours. Am. J. Clin. Pathol. 115, 543-549 (2001).
56. Wang, J., et al. B7-H3 associated with tumour progression and epigenetic regulatory activity in cutaneous melanoma. J. Invest. Dermatol. 133, 2050-2058 (2013).
57. Liu, C., et al. B7-H3 expression in ductal and lobular breast cancer and its association with IL-10. Mol. Med. Rep. 7, 134-138 (2013).
58. Palazón, A., et al. Agonist anti-CD137 mAb act on tumour endothelial cells to enhance recruitment of activated T lymphocytes. Cancer Res. 71, 801-811 (2011).
59. Ady, J. W., et al. Intercellular communication in malignant pleural mesothelioma: properties of tunneling nanotubes. Front. Physiol. 5, 400 (2014).
60. Goldman, A., et al. Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition. Nat. Commun. 6, 6139 (2015).